Papers

Adapting traditional content validation methods to fit purpose: an example with a novel video assessment and training materials in Duchenne muscular dystrophy (DMD)

by iTakeControl • July 13, 2019

Abstract Purpose The Duchenne muscular dystrophy (DMD) Video Assessment requires a caregiver to record six videos of their ambulatory child performing physical activities using a smartphone application (app). Innovative assessments that combine a performance measure, technology, and an observer require new approaches to content validation studies. This study presents a novel approach to establish the […]


The Case for the Use of Patient and Caregiver Perception of Change Assessments in Rare Disease Clinical Trials: A Methodologic Overview.

by iTakeControl • June 1, 2019

Check out a paper written by our partners Casimir Trials on the use of videos captured using iTakeControl’s platform Abstract INTRODUCTION: The traditional model of evaluating treatments based primarily on primary outcome measures has stumbled in its application to rare disease. Rare disease clinical trials face the methodological challenges of small, heterogeneous patient populations and […]


Video Assessment Outcome Measures for Muscular Dystrophy using a Validated Mobile Platform

by iTakeControl • May 18, 2018

Mobile health applications are still in their infancy but present a great opportunity for the healthcare industry. They enable patients to have a greater role in their health, empower providers to make data-driven decisions, allow researchers to gain greater insight into patient and disease populations, and give payers a new window into how patients are […]


White Paper – Managing Binge Eating Disorder with iTakeControl

by iTakeControl • January 17, 2018

Mobile health applications are still in their infancy but present a great opportunity for the healthcare industry. They enable patients to have a greater role in their health, empower providers to make data-driven decisions, allow researchers to gain greater insight into patient and disease populations, and give payers a new window into how patients are […]